Some reports have indicated that the levels of phase II enzymes, such as NQO1, are increased in cancer tissues compared with healthy tissues and that NQO1 stabilized the wild-type TP53, especially under oxidative stress [165]. This evidence concerns the gene TP53 and cancer.